Phosphate in early chronic kidney disease - associations with clinical outcomes and a target to reduce cardiovascular risk
Nephrology, 05/14/2012Toussainti ND et al.
High phosphate levels in chronic kidney disease (CKD) have been associated with increased all–cause mortality and cardiovascular morbidity and mortality. Observational studies have also demonstrated a consistent relationship between serum phosphate in the normal range and all–cause and cardiovascular mortality, left ventricular hypertrophy (LVH) and decline in renal function. Furthermore, fibroblast growth factor–23, a phosphaturic hormone, increases very early in the course of CKD and is strongly associated with death and cardiovascular disease, including LVH and vascular calcification.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.